As for NES, we found higher expression in BRAF+ melanoma than in BRAF− melanoma and significantly higher expression than in dysplastic nevus and melanoma in situ, emphasizing the significance of NES in melanoma progression. This evidence concerns the gene BRAF and dysplastic nevus.